PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\', \'Department of Internal Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan, ROC.\', \'Department of Medicine, Taipei Veteran General Hospital, Taipei, Taiwan, ROC.\', \'Division of Microbiology, Department of Pathology and Laboratory Medicine, Taipei, Taiwan, ROC.\', \'Division of Infectious Disease, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan, ROC.\', \'School of Medicine, Institute of Public Health, National Yang-Ming University, Taipei, Taiwan, ROC.\', \'School of Medicine, Institute of Physiology, National Yang-Ming University, Taipei, Taiwan, ROC.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/JCMA.0000000000000356
?:doi
?:hasPublicationType
?:journal
  • Journal of the Chinese Medical Association : JCMA
is ?:pmid of
?:pmid
?:pmid
  • 32433343
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Impact of the COVID-19 pandemic on the management of patients with end-stage renal disease.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all